Triple-way therapeutic approach for paraganglioma-dependent erythrocytosis: Drugs and surgery plus "multi-manner" apheresis

Medical Oncology

Volumn 25, Issue 2, 2008, Pages 148-153

  Todorovic, M ^a   Balint, B ^b,c   Suvajdzic, N ^a   Jevtic, M ^b   Pavlovic, M ^d   Petrovic, M ^a   Krstic, M ^a   Popovic, V ^a   Ivanovic, B ^a   Elezovic, I ^a   Milenkovic, R ^a   Colovic, M ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

"Multi manner" apheresis; Erythrocytosis; Erythropoietin; Paraganglioma; Relapse

Indexed keywords

ERYTHROPOIETIN;

ADULT; ANAMNESIS; APHERESIS; ARTICLE; BLOOD VISCOSITY; CANCER RELAPSE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; ERYTHROCYTOSIS; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERVISCOSITY SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHLEBOTOMY; PLASMAPHERESIS; PRIORITY JOURNAL; SKIN BIOPSY; BLOOD; MULTIMODALITY CANCER THERAPY; POLYCYTHEMIA; VISCOSITY;

ADULT; BLOOD COMPONENT REMOVAL; COMBINED MODALITY THERAPY; ERYTHROPOIETIN; FEMALE; HUMANS; PARAGANGLIOMA; POLYCYTHEMIA; VISCOSITY;

EID: 48049097786     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-007-9008-0     Document Type: Article

References (22)

1. Tischler A. The adrenal medulla and extra-adrenal paraganglia. In: Kovacs K, Asa S, editors. Functional endocrine pathology. Oxford, UK: Blackwell Scientific; 1998. p. 550-95.
2. B Ali-El-Dein A El-Sobky M El-Baz AA ShaaBan 2002 Abdominal and pelvic extra-adrenal paraganglioma: a review of literature and a report of 7 cases In Vivo 16 249 54
3. N Kuaka 2002 Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques Endocr Pathol 13 2 149 56
4. B Drenou 1995 Pheochromocytoma and secondary erythrocytosis: role of tumour erythropoietin secretion Nouv Rev Fr Hematol 37 3 197 9
5. ND Jalil 1998 Effectiveness and limits of preoperative imaging studies for the localization of pheochromocytomas and paragangliomas: a review of 282 cases Eur J Surg 164 23 8
6. N Terada 1994 Erythrocytosis complicated by multiple paraganglioma Acta Haematol 91 2 95 8
7. B Balint 2006 Cytapheresis in the treatment of cell-affected blood disorders and abnormalities Transf Apher Sci 35 1 25 31
8. B Balint and the National Apheresis Group 2005 Apheresis in donor and therapeutic settings: recruitments vs. possibilities - a multicenter study Transf Apher Sci 33 2 229 37
9. V Buonuomo 2004 Malignant paraganglioma: a case report and review of the literature Pediatr Hematol Oncol 21 731 8
10. JM Dionne 2006 Malignant hypertension, polycythemia, and paragangliomas J Pediatr 148 4 540 5
11. B Balint 2007 Simple "closed-circuit" group-specific immunoadsorption system for ABO-incompatible kidney transplants Transf Apher Sci 36 225 33
12. E Edström Elder 2003 KI-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma Mod Pathol 16 3 246 55
13. MA Rezkalla SN Rizk JJ Ryan 1995 Pheochromocytoma associated with polycythemia: case report S D J Med 48 10 349 51
14. V Chandra GB Thompson TC Bower SJ Taler 2004 Renal artery stenosis and a functioning hilar paraganglioma: a rare cause of renovascular hypertension-a case report Vasc Endovascular Surg 38 4 385 90
15. S Donnelly 2003 Why is erythropoietin made in the kidney? The kidney functions as a "critmeter" to regulate the hematocrit Adv Exp Med Biol 543 73 87
16. M Bosio G Barosi 1994 Postpheochromocytoma erythropoietin-dependent erythrocytosis. A postischemic mechanism? Am J Pediatr Hematol Oncol 16 4 365 7
17. T Imai 1986 A case of retroperitoneal multiple functioning paraganglioma Clin Endocrinol 11 175 7
18. T Imai 1988 Multiple functioning paraganglioma associated with polycythemia J Surg Oncol 39 4 279 82
19. TM Tekautz CB Pratt JJ Jenkin SL Spunt 2003 Pediatric extrarenal paraganglioma J Pediatr Surg 38 1317 21
20. M Messinezy TC Pearson 1993 Apparent polycythaemia: diagnosis, pathogenesis and management Eur J Haematol 51 125 31
21. LY Shih JY Huang CT Lee 1999 Insulin-like growth factor I plays a role in regulating erythropoiesis in patients with end-stage renal disease and erythrocytosis J Am Soc Nephrol 10 315 22
22. B Myers SM Donohue 2002 A case of sickle-cell erythrocytosis occurring following renal transplantation Clin Lab Haematol 24 3 175 7